Park Avenue Securities’s Elanco Animal Health ELAN Stock Holding History

Park Avenue Securities’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-23,559	Closed	-$462K	–	1128
2022 Q2	$462K	Buy	23,559 +2,118	+10%	+$50.1K	0.01%	742
2022 Q1	$559K	Buy	21,441 +5,418	+34%	+$144K	0.01%	695
2021 Q4	$455K	Buy	16,023 +4,216	+36%	+$131K	0.01%	747
2021 Q3	$377K	Buy	11,807 +1,978	+20%	+$66.4K	0.01%	767
2021 Q2	$341K	Buy	9,829 +1,942	+25%	+$64K	0.01%	787
2021 Q1	$232K	Buy	+7,887	New	+$243K	0.01%	876
2020 Q1	–	Sell	-9,529	Closed	-$281K	–	373
2019 Q4	$281K	Buy	+9,529	New	+$259K	0.01%	485

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Park Avenue Securities's ELAN Position: Q3 2022 in Review

Park Avenue Securities sold out of Elanco Animal Health (ELAN) in Q3 2022, closing a stake of 23,559 shares — an estimated $462K sold.

Park Avenue Securities first reported a position in ELAN in Q4 2019 and held it in 7 quarters. The position peaked at $559K in Q1 2022. 419 funds tracked by Wall St. Rank hold ELAN as of Q3 2022.

Park Avenue Securities reported no remaining Elanco Animal Health position as of Q3 2022 after selling out during the quarter.
Park Avenue Securities sold 23,559 Elanco Animal Health shares in Q3 2022, an estimated $462K.
Park Avenue Securities first reported a position in Elanco Animal Health in Q4 2019 and held it in 7 quarters.
Park Avenue Securities's Elanco Animal Health position peaked at $559K in Q1 2022.
419 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2022.

Based on Park Avenue Securities's 13F filing for Q3 2022, filed 1 Nov 2022.